2022-10-25-上交所-普莱柯2022年第三季度报告_12页_400kb

报告摘要

Revenue: Total revenue for the first nine months of 2022 was RMB 313,002,919.03, representing a 29.45% increase compared to the same period in 2021.
Net Profit: Net profit attributable to shareholders for Q3 2022 was RMB 52,592,824.07, showing a decline of 21.54% year-over-year. Full-year 2022 net profit was RMB 132,851,899.04, down 42.40% from the previous year.
Cash Flow: Operating activities generated RMB 174,610,531.94, with growth of 32.51% compared to the same period 2021. Revenue streams saw mixed results: porcine vaccines increased by 4.28%, avian vaccines and antibodies decreased by 4.02%, and chemical products dropped by 3.18%. Key drivers included non-operating gains and changes in working capital.
Shareholders: Top shareholders include Zhang XuKe, holding approximately 30.97% (109,299,168 shares), and other significant contributors like SinoKeeper Agriculture Co., Ltd. and individual investors. Total shares outstanding were 352,916,573 as of September 30, 2022.
Overall: Despite revenue growth, profit decreased, attributed to factors such as increased accounts receivable and reduced investment returns, with no major extraordinary events or incentives impacting the results.